Genetic Engineering & Biotechnology News

Since its inception in 1981, Genetic Engineering & Biotechnology News (GEN) has established itself as the leading publication in the biotech field. GEN offers a print edition 21 times each year, along with a wealth of exclusive online content that includes news updates, in-depth analysis, webinars, videos, and surveys. The publication's distinct emphasis on news and technology spans the full bioproduct life cycle, covering areas such as drug discovery, initial research and development, applied research (like omics, biomarkers, and diagnostics), bioprocessing, and the commercialization process.

National, Trade/B2B

English

Magazine

Outlet metrics

Domain Authority

Ranking

Global

#238534

United States

#108661

Science and Education/Biology

#223

Traffic sources

Monthly visitors

Articles

Make Bioprocesses More Efficient by Making Them Less Complex

2 days ago | genengnews.com | Gail Dutton

Home Topics Bioprocessing Make Bioprocesses More Efficient by Making Them Less Complex Credit: Koldoy Chris/Getty Images Credit: Koldoy Chris/Getty Images “The best way to make things efficient and repeatable is to make them less complex.”That’s the opinion of Josh Ludwig, global commercial director at ScaleReady, and the guiding principle of lean manufacturing. For biopharma entrepreneurs, it’s never too early to take that message to heart.
Working Long Hours May Alter Brain Structure in Healthcare Workers

2 days ago | genengnews.com | Sophia Ktori

Results highlight importance of addressing overwork as an occupational health concern, and the need for workplace policies to mitigate excessive working hours.
ASGCT 2025: EG 427 Makes Strides in Non-Replicative HSV-1 Vectors for Neurological Therapies

3 days ago | genengnews.com | Uduak Grace Thomas

Home Topics Drug Discovery ASGCT 2025: EG 427 Makes Strides in Non-Replicative HSV-1 Vectors for Neurological... Herpes simplex virus HSV cell [quantic69]. Herpes simplex virus HSV cell [quantic69]. At this year’s annual meeting of the American Society of Gene and Cell Therapy (ASGCT), French biotechnology company EG 42 will share recent advances in the development of its recombinant, non-replicating HSV-1 (nrHSV-1) vector technology.
Biopharma Stocks Rise as Trump Orders Drug Price Cuts

3 days ago | genengnews.com | Alex Philippidis

Home Topics Drug Discovery Biopharma Stocks Rise as Trump Orders Drug Price Cuts President Donald Trump signed an executive order to lower U.S. prescription drug prices to their levels in other countries, Looking on at left is NIH Director Jayanta “Jay” Bhattacharya, MD, PhD.
Genentech Plans to Invest More than $700 Million in New North Carolina Drug Manufacturing Facility

3 days ago | genengnews.com | John Sterling

Home Topics Bioprocessing Genentech Plans to Invest More than $700 Million in New North Carolina... Female researcher looking through microscope in a laboratory. [Roche/Genentech] Female researcher looking through microscope in a laboratory. [Roche/Genentech] Genentech plans to invest more than $700 million in a new 700,000-ft2 drug manufacturing facility in Holly Springs, NC.
How Bacteria Synthesize an “Organic Dishwashing Liquid” to Degrade Oil

1 week ago | genengnews.com | John Sterling

Home News How Bacteria Synthesize an “Organic Dishwashing Liquid” to Degrade Oil Oil slick on sea surface. [Sergei Dubrovskii/Getty Images] Oil slick on sea surface. [Sergei Dubrovskii/Getty Images] The marine bacterium Alcanivorax borkumensis feeds on oil, multiplying rapidly in the wake of oil spills and thereby accelerating the elimination of the pollution, in many cases. It does this by producing an “organic dishwashing liquid,” which it uses to attach itself to oil droplets.
Ansa Biotechnologies Rolls Out Early Access Program for Long, Complex Synthetic DNA Orders

1 week ago | genengnews.com | Uduak Grace Thomas

Home News Ansa Biotechnologies Rolls Out Early Access Program for Long, Complex Synthetic DNA... Credit: Aleksandr Semenov / iStock / Getty Images Plus Credit: Aleksandr Semenov / iStock / Getty Images Plus Last year, during the Global Synthetic Biology (SynBioBeta) conference, Ansa Biotechnologies’ CEO Jason Gammack introduced attendees to the company’s first product—600 bp synthetic DNA constructs.
In Vivo Bioprinting Shows Promise for 3D Printed Implants Without Surgery

1 week ago | genengnews.com | Sophia Ktori

Home News In Vivo Bioprinting Shows Promise for 3D Printed Implants Without Surgery Credit: Frame Studio / Getty Images Credit: Frame Studio / Getty Images Researchers headed by a team at the California Institute of Technology developed an ultrasound-guided 3D printing technique that could make it possible to fabricate medical implants in vivo and deliver tailored therapies to tissues deep inside the body—all without invasive surgery.
AI Designed DNA Sequences Modulate Cell Differentiation for Gene Therapy Applications

1 week ago | genengnews.com | Fay Y. Lin

Home Topics Artificial Intelligence AI Designed DNA Sequences Modulate Cell Differentiation for Gene Therapy Applications Digital DNA. Technology Concept. 3D Render Credit: BlackJack3D / 1465763073 / iStock / Getty Images Plus For stem cells to differentiate into the appropriate cell-type, transcription factors (TFs) must be tailored to highly specific expression patterns of lineage-specific genes.
First-time Production of an Artificial Human Platelet Lysate

1 week ago | genengnews.com | John Sterling

Home Topics Bioprocessing First-time Production of an Artificial Human Platelet Lysate Credit: Manjurul/Getty Images Credit: Manjurul/Getty Images PL BioScience, a German life science company specializing in the production and development of human platelet lysate (HPL) for cell expansion, reported the first-time production of an artificial HPL cell culture solution.